News
BVS
5.12
+28.00%
1.12
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
U.S. Stocks traded mixed on Tuesday, with the Nasdaq Composite falling around 0.2%. The Dow traded up 0.01% to 38,857.00 while the NASDAQ fell 0.20%. Great Lakes Dredge & Dock Corporation shares jumped 24% on Tuesday following better-than-expected first-quarter results. Asian markets closed mixed; European shares were higher today.
Benzinga · 20h ago
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Beyond, Inc. Shares dipped 20.8% to $17.34 on Tuesday. The company posted weaker-than-expected quarterly results. Beyond posted adjusted loss of $1.22 per share, versus estimates for a loss of 87 cents per share. Golden Sun Health Technology Group Limited shares gained 94.7% in today's mid-day session.
Benzinga · 20h ago
Bioventus Inc reports results for the quarter ended in March - Earnings Summary
Bioventus Inc reported quarterly adjusted earnings of 7 cents per share for the quarter ended in March. The company reported a quarterly loss of $4.57 million. Revenue rose 8.7% to $129.46 million from a year ago. BioventUS Inc shares had fallen by 23.1% this quarter.
Reuters · 22h ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Nuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's, Q1 earnings report came out today. Bioventus stock moved upwards by 28.87% and Design Therapeutics stock rose 28.49%.
Benzinga · 22h ago
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q1 2024
Bioventus reported earnings per share of 7 cents for the first quarter of 2024. The company reported revenue of $129.46 million. This was 9.36% better than the analyst estimate for revenue. Biovents also reported results for the fourth quarter of 2015.
Investorplace · 23h ago
Bioventus Up Nearly 22%, On Track for Largest Percent Increase Since May 2023 -- Data Talk
Bioventus, Inc. Class A (BVS) is currently at $4.88, up $0.88 or 21.88%. Up four of the past five days; up 23.11% month-to-date. Up 406.18% from its 52-week closing high of $19.21.
Dow Jones · 23h ago
Bioventus Shares Rise 23% After Narrower-Than-Expected 1Q Loss
Bioventus shares were up 23% to $4.91 in recent trading. The medical-treatment company reported a first-quarter loss that was narrower than analysts' expectations. The company raised its 2024 sales guidance to $535 million to $550 million. Sales for the quarter were $129.5 million.
Dow Jones · 1d ago
BUZZ-Bioventus gains after raising annual sales, profit forecasts
Shares of medical device company Bioventus BVS.O rise 19% to $4.77. Company raises annual sales, profit forecasts. Co expects annual sales of $535 million to $550 million. Company posts Q1 revenue of $129.5 million, above analysts' estimate of $118.38 million.
Reuters · 1d ago
Bioventus Raises 2024 Guidance: Now Expects Net Sales Of $535M-$550M (Prior $520M-$535M) Vs. $528.033M Est., And Adj. EPS Of $0.25 To $0.33 (Prior $0.12-$0.20) Vs. $0.16 Est.
Bioventus raises financial guidance for full-year 2024. The company now expects net sales of $535 million to $550 million. Company says strong execution and momentum across the business is behind the increase. The company also raised its non-GAAP earnings guidance.
Benzinga · 1d ago
*Bioventus Sees 2024 Sales $535M-$550M >BVS
Dow Jones · 1d ago
BIOVENTUS INC - SEES 2024 NON-GAAP EPS OF $0.25 TO $0.33
Reuters · 1d ago
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Ligand Pharma (LGND) and Bioventus (BVS)
TipRanks · 2d ago
Weekly Report: what happened at BVS last week (0429-0503)?
Weekly Report · 2d ago
Weekly Report: what happened at BVS last week (0422-0426)?
Weekly Report · 04/29 09:14
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
Bioventus Inc. Will report financial results for the first quarter of fiscal year 2024 before the market opens on Tuesday, May 7, 2024. The Company's management will host a conference call to discuss the results and provide a business update. The company is a global leader in innovations for active healing.
Barchart · 04/29 06:30
Weekly Report: what happened at BVS last week (0415-0419)?
Weekly Report · 04/22 09:13
Weekly Report: what happened at BVS last week (0408-0412)?
Weekly Report · 04/15 09:13
Weekly Report: what happened at BVS last week (0401-0405)?
Weekly Report · 04/08 09:13
Weekly Report: what happened at BVS last week (0325-0329)?
Weekly Report · 04/01 09:13
Weekly Report: what happened at BVS last week (0318-0322)?
Weekly Report · 03/25 09:13
More
Webull provides a variety of real-time BVS stock news. You can receive the latest news about Bioventus Inc. through multiple platforms. This information may help you make smarter investment decisions.
About BVS
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.